Patients with myelodysplastic syndrome (MDS) who have TET2/IDH mutations have been found to show a distinct phenotype in their natural killer (NK) cells (22). This suggests that these mutations are present in NK cells and are associated with changes in both phenotype and function (22). The gene discussed is TET2; the disease is myelodysplastic syndrome.